OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulatory Nanosystems
Xiangru Feng, Weiguo Xu, Zhongmin Li, et al.
Advanced Science (2019) Vol. 6, Iss. 17
Open Access | Times Cited: 318

Showing 1-25 of 318 citing articles:

A Multifunctional Cascade Bioreactor Based on Hollow‐Structured Cu₂MoS₄ for Synergetic Cancer Chemo‐Dynamic Therapy/Starvation Therapy/Phototherapy/Immunotherapy with Remarkably Enhanced Efficacy
Mengyu Chang, Man Wang, Meifang Wang, et al.
Advanced Materials (2019) Vol. 31, Iss. 51
Closed Access | Times Cited: 441

Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment
Mi Zhang, Wenhui Hu, Chenhui Cai, et al.
Materials Today Bio (2022) Vol. 14, pp. 100223-100223
Open Access | Times Cited: 240

Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Jin Zhang, Yandai Lin, Zhe Lin, et al.
Advanced Science (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 195

Absorbable Thioether Grafted Hyaluronic Acid Nanofibrous Hydrogel for Synergistic Modulation of Inflammation Microenvironment to Accelerate Chronic Diabetic Wound Healing
Sha Liu, Qingfei Zhang, Jie Yu, et al.
Advanced Healthcare Materials (2020) Vol. 9, Iss. 11
Closed Access | Times Cited: 174

Recent Advances in Engineered Materials for Immunotherapy‐Involved Combination Cancer Therapy
Jun‐Long Liang, Guo‐Feng Luo, Wei‐Hai Chen, et al.
Advanced Materials (2021) Vol. 33, Iss. 31
Closed Access | Times Cited: 166

Biocompatibility of nanomaterials and their immunological properties
Themis R. Kyriakides, Arindam Raj, Tiffany H Tseng, et al.
Biomedical Materials (2021) Vol. 16, Iss. 4, pp. 042005-042005
Open Access | Times Cited: 154

Engineering the drug carrier biointerface to overcome biological barriers to drug delivery
Joel A. Finbloom, Flávia Sousa, Molly M. Stevens, et al.
Advanced Drug Delivery Reviews (2020) Vol. 167, pp. 89-108
Open Access | Times Cited: 146

Self-Delivery Photo-Immune Stimulators for Photodynamic Sensitized Tumor Immunotherapy
Linping Zhao, Rongrong Zheng, Jiaqi Huang, et al.
ACS Nano (2020) Vol. 14, Iss. 12, pp. 17100-17113
Closed Access | Times Cited: 143

A “Closed‐Loop” Therapeutic Strategy Based on Mutually Reinforced Ferroptosis and Immunotherapy
Yaqian Du, Rui Zhang, Jiani Yang, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 13
Closed Access | Times Cited: 140

Role of copper nanoparticles in wound healing for chronic wounds: literature review
Jessica Salvo, Cristian Sandoval
Burns & Trauma (2021) Vol. 10
Open Access | Times Cited: 116

Deploying Gold Nanomaterials in Combating Multi-Drug-Resistant Bacteria
Xiaohui Zhao, Hao Tang, Xingyu Jiang
ACS Nano (2022) Vol. 16, Iss. 7, pp. 10066-10087
Closed Access | Times Cited: 105

Towards principled design of cancer nanomedicine to accelerate clinical translation
Mohammad Souri, M. Soltani, Farshad Moradi Kashkooli, et al.
Materials Today Bio (2022) Vol. 13, pp. 100208-100208
Open Access | Times Cited: 100

Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy
Zili Zhang, Haifeng Zhou, Xiaohu Ouyang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 93

Metallic Nanosystems in the Development of Antimicrobial Strategies with High Antimicrobial Activity and High Biocompatibility
Karol Skłodowski, Sylwia Joanna Chmielewska-Deptuła, Ewelina Piktel, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2104-2104
Open Access | Times Cited: 71

Nanoparticle-mediated cancer cell therapy: basic science to clinical applications
Jaya Verma, Caaisha Warsame, Rajkumar Kottayasamy Seenivasagam, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 601-627
Open Access | Times Cited: 57

Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis
Yuyi Xu, Ming Zhao, Jinxue Cao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4417-4441
Open Access | Times Cited: 46

Theranostic applications of selenium nanomedicines against lung cancer
Shaowei Liu, Weifeng Wei, Jinlin Wang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 44

Microenvironment-responsive nanocarriers for targeted bone disease therapy
Mengmeng Li, Biao Yu, Sicheng Wang, et al.
Nano Today (2023) Vol. 50, pp. 101838-101838
Closed Access | Times Cited: 43

Progress and prospects on vaccine development against monkeypox infection
Mohamed J. Saadh, Tahmineh Ghadimkhani, Narges Soltani, et al.
Microbial Pathogenesis (2023) Vol. 180, pp. 106156-106156
Open Access | Times Cited: 43

Employing Piezoelectric Mg²⁺‐Doped Hydroxyapatite to Target Death Receptor‐Mediated Necroptosis: A Strategy for Amplifying Immune Activation
Jiani Yang, Yaqian Du, Yuanfei Yao, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 16

TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages
Zhipeng Liu, Yue Xie, Yao Xiong, et al.
Cancer Letters (2019) Vol. 469, pp. 173-185
Closed Access | Times Cited: 136

Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines
Daniel Shae, Jessalyn J. Baljon, Mohamed Wehbe, et al.
ACS Nano (2020) Vol. 14, Iss. 8, pp. 9904-9916
Open Access | Times Cited: 129

Nanoenabled Disruption of Multiple Barriers in Antigen Cross-Presentation of Dendritic Cells via Calcium Interference for Enhanced Chemo-Immunotherapy
Jingyi An, Kaixiang Zhang, Binghua Wang, et al.
ACS Nano (2020) Vol. 14, Iss. 6, pp. 7639-7650
Closed Access | Times Cited: 117

Immunoadjuvants for cancer immunotherapy: A review of recent developments
Asmita Banstola, Jee‐Heon Jeong, Simmyung Yook
Acta Biomaterialia (2020) Vol. 114, pp. 16-30
Closed Access | Times Cited: 107

Page 1 - Next Page

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 1-25 of 318 citing articles:

Your Privacy